Literature DB >> 16338746

Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis.

Francesca Bagnato1, John A Butman, Carlos A Mora, Shiva Gupta, Yoshima Yamano, Talin A Tasciyan, Jeffrey M Solomon, Waldyr J Santos, Roger D Stone, Henry F McFarland, Steven Jacobson.   

Abstract

Conventional brain and spinal cord magnetic resonance images were performed in 21 patients with human T-cell lymphotropic virus (HTLV)-1 associated myelopathy/tropical spastic paraparesis, to assess the role of conventional magnetic resonance imaging (MRI) in the disease diagnosis. These patients had no other central nervous system conditions or related risk factors at the time of tropical spastic paraparesis diagnosis. Eleven (52.4%) patients showed nonspecific brain abnormalities on T2-weighted images. The majority (77.2%) of brain abnormalities were located in the deep white matter. A transient contrast-enhancing lesion was identified in the brain of only one patient. In the brain of another patient, 9.0% of the T2-hyperintense lesion load was hypointense on the correspondent T1-weighted images. No differences in terms of demographic, biological, or clinical variables were present between patients with abnormal brain images and those with normal brain magnetic resonance images. Spinal cord T2-weighted images were abnormal in three (14.3%) patients. In one of these three patients, a diffuse but transient edema was found along the entire tract of the spinal cord. White matter lesions were present in the central nervous system of 60% of the cases in this study. However, no correlations between magnetic resonance imaging and clinical findings, and no specificity of lesions were observed. Hence, conventional magnetic resonance imaging is a sensitive but not highly specific tool for diagnosis of tropical spastic paraparesis.

Entities:  

Mesh:

Year:  2005        PMID: 16338746     DOI: 10.1080/13550280500385039

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  40 in total

Review 1.  Imaging of the spine in multiple sclerosis.

Authors:  S J Hickman; D H Miller
Journal:  Neuroimaging Clin N Am       Date:  2000-11       Impact factor: 2.264

2.  MRI contributes to the differentiation between MS and HTLV-I associated myelopathy in British Columbian coastal natives.

Authors:  Andrew K Howard; David K B Li; Joël Oger
Journal:  Can J Neurol Sci       Date:  2003-02       Impact factor: 2.104

3.  HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings.

Authors:  M Nakagawa; S Izumo; S Ijichi; H Kubota; K Arimura; M Kawabata; M Osame
Journal:  J Neurovirol       Date:  1995-03       Impact factor: 2.643

4.  Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease.

Authors:  M C Levin; T J Lehky; A N Flerlage; D Katz; D W Kingma; E S Jaffe; J D Heiss; N Patronas; H F McFarland; S Jacobson
Journal:  N Engl J Med       Date:  1997-03-20       Impact factor: 91.245

5.  IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease.

Authors:  M Jernigan; Y Morcos; S M Lee; F C Dohan; C Raine; M C Levin
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

6.  Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.

Authors:  S Jacobson; H Shida; D E McFarlin; A S Fauci; S Koenig
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

7.  Tropical spastic paraparesis and human T cell lymphotropic virus type 1 in the United Kingdom.

Authors:  J K Cruickshank; P Rudge; A G Dalgleish; M Newton; B N McLean; R O Barnard; B E Kendall; D H Miller
Journal:  Brain       Date:  1989-08       Impact factor: 13.501

8.  Leukoencephalopathy in HTLV-I-associated myelopathy: MRI and EEG data.

Authors:  J Kira; S Minato; Y Itoyama; I Goto; M Kato; K Hasuo
Journal:  J Neurol Sci       Date:  1988-11       Impact factor: 3.181

Review 9.  Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I).

Authors:  A Gessain; O Gout
Journal:  Ann Intern Med       Date:  1992-12-01       Impact factor: 25.391

Review 10.  The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis.

Authors:  F Fazekas; F Barkhof; M Filippi; R I Grossman; D K Li; W I McDonald; H F McFarland; D W Paty; J H Simon; J S Wolinsky; D H Miller
Journal:  Neurology       Date:  1999-08-11       Impact factor: 9.910

View more
  16 in total

1.  In vivo detection of cortical plaques by MR imaging in patients with multiple sclerosis.

Authors:  F Bagnato; J A Butman; S Gupta; M Calabrese; L Pezawas; J M Ohayon; F Tovar-Moll; M Riva; M M Cao; S L Talagala; H F McFarland
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

2.  Brain volume measurements in patients with human T-cell lymphotropic virus-1-associated tropical spastic paraparesis.

Authors:  C Griffith; F Bagnato; S Gupta; A Calabrese; U Oh; A Chiu; J M Ohayon; M J McAuliffe; T A Tasciyan; S Jacobson
Journal:  J Neurovirol       Date:  2006-10       Impact factor: 2.643

3.  Ring and nodular multiple sclerosis lesions: a retrospective natural history study.

Authors:  M Davis; S Auh; M Riva; N D Richert; J A Frank; H F McFarland; F Bagnato
Journal:  Neurology       Date:  2010-03-09       Impact factor: 9.910

4.  In vivo imaging of spinal cord atrophy in neuroinflammatory diseases.

Authors:  Winston Liu; Govind Nair; Luisa Vuolo; Anshika Bakshi; Raya Massoud; Daniel S Reich; Steven Jacobson
Journal:  Ann Neurol       Date:  2014-07-22       Impact factor: 10.422

5.  Clinical manifestations in individuals with recent diagnosis of HTLV type I infection.

Authors:  Shelene K W Poetker; Aurelia F Porto; Silvana P Giozza; Andre L Muniz; Marina F Caskey; Edgar M Carvalho; Marshall J Glesby
Journal:  J Clin Virol       Date:  2011-03-08       Impact factor: 3.168

Review 6.  Cerebral and spinal cord changes observed through magnetic resonance imaging in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis: a systematic review.

Authors:  Ana Patrícia Bastos Ferreira; Ana Dolores Firmino Santos do Nascimento; Pedro Augusto Sampaio Rocha-Filho
Journal:  J Neurovirol       Date:  2022-01-03       Impact factor: 2.643

7.  Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP.

Authors:  Daniel J Morgan; Marina F Caskey; Cristiane Abbehusen; Jamary Oliveira-Filho; Cesar Araujo; Aurelia F Porto; Silvane Braga Santos; Gloria O Orge; Maria Jose Joia; Andre L Muniz; Isadora Siqueira; Marshall J Glesby; Edgar Carvalho
Journal:  AIDS Res Hum Retroviruses       Date:  2007-12       Impact factor: 2.205

8.  Tissue-specific imaging is a robust methodology to differentiate in vivo T1 black holes with advanced multiple sclerosis-induced damage.

Authors:  M Riva; V N Ikonomidou; J J Ostuni; P van Gelderen; S Auh; J M Ohayon; F Tovar-Moll; N D Richert; J H Duyn; F Bagnato
Journal:  AJNR Am J Neuroradiol       Date:  2009-04-30       Impact factor: 3.825

9.  Multisequence-imaging protocols to detect cortical lesions of patients with multiple sclerosis: observations from a post-mortem 3 Tesla imaging study.

Authors:  Francesca Bagnato; Bing Yao; Fredric Cantor; Hellmut Merkle; Ellen Condon; Marcela Montequin; Sandra Moore; Martha Quezado; Deborah Tkaczyk; Henry McFarland
Journal:  J Neurol Sci       Date:  2009-04-23       Impact factor: 3.181

Review 10.  [HTLV-1-associated myelopathy/tropical spastic paraparesis: a differential diagnosis in multiple sclerosis].

Authors:  A Liesz; S Hähnel; K Korn; M Esiri; W Hacke; B Wildemann
Journal:  Nervenarzt       Date:  2012-08       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.